Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observer-blind Safety and Immunogenicity Study of GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A When Administered to Elderly Subjects.

NCT00760617 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00760617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00760617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observer-blind Safety and Immunogenicity Study of GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A When Administered to Elderly Subjects.
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
October 6, 2008
Completion date
May 15, 2009
Enrollment
526 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

influenza